CCBG(CCBG)
CCBG
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $258M | $267M |
| Low | $258M | $267M |
| High | $258M | $267M |
| EBITDA Avg | $73M | $75M |
| Low | $73M | $75M |
| High | $73M | $75M |
| EBIT Avg | $65M | $67M |
| Low | $65M | $67M |
| High | $65M | $67M |
| Net Income Avg | $62M | $63M |
| Low | $62M | $63M |
| High | $62M | $63M |
| EPS Avg | $3.62 | $3.67 |
| Low | $3.62 | $3.67 |
| High | $3.62 | $3.67 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $65M | $65M | $65M | $67M | $68M | $67M |
| Low | $65M | $65M | $65M | $67M | $68M | $67M |
| High | $65M | $65M | $65M | $67M | $68M | $67M |
| EBITDA Avg | $18M | $18M | $18M | $19M | $19M | $19M |
| Low | $18M | $18M | $18M | $19M | $19M | $19M |
| High | $18M | $18M | $18M | $19M | $19M | $19M |
| EBIT Avg | $16M | $16M | $16M | $17M | $17M | $17M |
| Low | $16M | $16M | $16M | $17M | $17M | $17M |
| High | $16M | $16M | $16M | $17M | $17M | $17M |
| Net Income Avg | $16M | $15M | $15M | $16M | $16M | $15M |
| Low | $16M | $15M | $15M | $16M | $16M | $15M |
| High | $16M | $15M | $15M | $16M | $16M | $15M |
| EPS Avg | $0.91 | $0.88 | $0.88 | $0.91 | $0.94 | $0.89 |
| Low | $0.91 | $0.88 | $0.88 | $0.91 | $0.94 | $0.89 |
| High | $0.91 | $0.88 | $0.88 | $0.91 | $0.94 | $0.89 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |